Brennan Boyd, MD
Ophthalmology · Phoenix, AZNPI 1174146476
Payments from drug & device makers
Across 81 payments — averaging $56.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- Bausch & Lomb Americas Inc.$641
- Johnson & Johnson Surgical Vision, Inc.$393
- Alcon$292
- Glaukos Corporation$287
- Genentech USA, Inc.$276
- plus $2K from 12 others
What the payments were for
- Food & beverage$4,537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 24 | $1,081 |
| Bausch & Lomb Americas Inc. | 7 | $641 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $393 |
| Alcon | 3 | $292 |
| Glaukos Corporation | 2 | $287 |
| Genentech USA, Inc. | 5 | $276 |
| Apellis Pharmaceuticals, Inc. | 5 | $262 |
| Astellas Pharma US Inc | 10 | $257 |
| Carl Zeiss Meditec USA, Inc. | 1 | $190 |
| Regeneron | 2 | $182 |
| AbbVie | 7 | $151 |
| Amgen | 1 | $123 |
| Harrow Eye, LLC | 3 | $96 |
| Dompe US, Inc. | 1 | $95 |
| Alimera Sciences, Inc. | 3 | $69 |
| Dutch Ophthalmic, USA | 1 | $62 |
| ANI Pharmaceuticals, Inc. | 3 | $55 |
| Genentech, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$489
- iStent Trabecular Micro-Bypass System Model iS3$287
- Clareon$265
- LIPIFLOW SYSTEM ACTIVATOR II (DISPOSABLE$262
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$262
- MEIBOMIAN GLAND EVALUATOR$262
- LIPIVIEW OCULAR SURFACE INTERFEROMETER$262
- STELLARIS ELITE$182
- STELLARIS$155
- VABYSMO$154
- AMO PHACO NEEDLE$131
- Syfovre$125
- TEPEZZA$123
- MIEBO$121
- XIIDRA$121
- enVista MX60 IOL$121
- TORIC$117
- EYLEA$103
How this compares
$4,537 in reported general payments places this provider in the 70th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Phoenix
- Ramin SchadluPhoenix$1.8M
- John CasonPhoenix$1.7M
- Benjamin HellerPhoenix$1.1M
- Neal PalejwalaPhoenix$627K
- Pravin DugelPhoenix$479K
- Robert GrossPhoenix$268K
- Sujit IttyPhoenix$216K
- Jung DaoPhoenix$213K
- Karim JamalPhoenix$101K
- Nishi ShahPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.